
Brand Name | Status | Last Update |
|---|---|---|
| papaverine hydrochloride | unapproved drug other | 2025-02-11 |
Code | Description |
|---|---|
| J2440 | Injection, papaverine hcl, up to 60 mg |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Peripheral arterial disease | D058729 | EFO_0004265 | — | — | — | — | — | 1 | 1 |
| Chronic limb-threatening ischemia | D000089802 | — | — | — | — | — | — | 1 | 1 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | — | — | 1 | 1 |
| St elevation myocardial infarction | D000072657 | — | — | — | — | — | — | 1 | 1 |
| Infarction | D007238 | EFO_0009463 | — | — | — | — | — | 1 | 1 |
| Drug common name | Papaverine |
| INN | — |
| Description | Papaverine is a benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum. It has a role as a vasodilator agent and an antispasmodic drug. It is a benzylisoquinoline alkaloid, a member of isoquinolines and a dimethoxybenzene. |
| Classification | Small molecule |
| Drug class | spasmolytic agents (papaverine type) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC |
| PDB | — |
| CAS-ID | 58-74-2 |
| RxCUI | — |
| ChEMBL ID | CHEMBL19224 |
| ChEBI ID | 28241 |
| PubChem CID | 4680 |
| DrugBank | DB01113 |
| UNII ID | — |





